Scenario name,Rate of gonorrhea cases,"% cases successfully treated with CIP, TET, or CRO",% cases susceptible to CIP,% cases susceptible to TET,% cases susceptible to CRO,"Effective lifespan of CIP, TET, and CRO",Effective lifespan of CIP,Effective lifespan of TET,Effective lifespan of CRO,delta - Rate of gonorrhea cases,"delta - Effective lifespan of CIP, TET, and CRO",delta - Effective lifespan of CIP,delta - Effective lifespan of TET,delta - Effective lifespan of CRO
Status quo (no rapid test),"8,093 (6,926, 9,087)","35.4% (31.2%, 39.8%)","73.5% (69.3%, 75.6%)","16.9% (14.8%, 19.3%)","95.2% (94.5%, 95.7%)","12.4 (10.9, 13.9)","25.7 (24.3, 26.5)","5.9 (5.2, 6.8)","33.3 (33.1, 33.5)",,,,,
"p=(None, None), q=(None, None), c=0.500, f=1.00)","8,370 (7,301, 9,343)","46.2% (37.1%, 56.5%)","68.6% (64.5%, 71.2%)","15.2% (13.1%, 17.7%)","96.1% (95.6%, 96.6%)","16.2 (13.0, 19.8)","24.0 (22.6, 24.9)","5.3 (4.6, 6.2)","33.6 (33.5, 33.8)","3.6% (1.0%, 5.4%)","29.4% (19.1%, 42.0%)","-6.6% (-8.0%, -4.5%)","-10.3% (-13.9%, -8.4%)","0.9% (0.5%, 1.5%)"
"p=(None, None), q=(None, None), c=0.750, f=1.00)","8,588 (7,545, 9,637)","46.8% (39.9%, 56.1%)","66.4% (61.6%, 69.4%)","14.4% (12.3%, 17.1%)","95.2% (94.2%, 96.7%)","16.4 (14.0, 19.6)","23.3 (21.6, 24.3)","5.0 (4.3, 6.0)","33.3 (33.0, 33.8)","6.3% (3.4%, 9.0%)","32.0% (22.3%, 42.2%)","-9.6% (-11.2%, -6.9%)","-15.1% (-17.1%, -11.7%)","-0.1% (-1.2%, 2.3%)"
"p=(None, None), q=(None, None), c=1.000, f=1.00)","8,718 (7,658, 9,692)","44.7% (39.6%, 51.0%)","65.8% (61.2%, 68.7%)","14.0% (11.8%, 16.7%)","95.8% (94.2%, 96.9%)","15.7 (13.9, 17.8)","23.0 (21.4, 24.0)","4.9 (4.1, 5.8)","33.5 (33.0, 33.9)","8.0% (4.6%, 10.6%)","26.3% (22.2%, 28.6%)","-10.6% (-12.7%, -7.9%)","-17.4% (-20.0%, -13.8%)","0.6% (-1.0%, 1.9%)"
